r.iyer
Submits third-party assay reports on material purchased directly. Based in Accra.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
98.19%
n=9
Suppliers covered
9
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043330 | Liraglutide | CPC | CPC-2602-G1978 | Janoshik | 2026-Q3 | 97.90 | 4.58 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041274 | Liraglutide | WWB | WWB-2607-X2189 | Janoshik | 2026-Q3 | 99.55 | 4.62 | 89.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043535 | CJC-1295 with DAC | BCH | BCH-2607-H7307 | Janoshik | 2026-Q3 | 97.56 | 5.31 | 107.4 | Laboratory-retained | 1 | MARGINAL |
| AX-2026-042325 | Tirzepatide | HJ | HJ-2605-D3120 | PeptideMeter | 2026-Q2 | 97.85 | 4.36 | 90.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042695 | Retatrutide | GGPeps | GGPE-2512-D9394 | Janoshik | 2026-Q2 | 98.19 | 3.76 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018755 | TB-500 | QSC | QSC-2505-C7889 | Kestrel | 2025-Q4 | 99.41 | 3.31 | 100.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019677 | Tirzepatide | Homopeptide | HOMO-2509-U2115 | Janoshik | 2025-Q4 | 98.66 | 2.72 | 92.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018656 | Semaglutide | QYB | QYB-2505-U5789 | Nordanalyt | 2025-Q3 | 98.98 | 3.94 | 91.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020608 | Retatrutide | SSA | SSA-2507-W7338 | Nordanalyt | 2025-Q3 | 97.68 | 2.95 | 103.0 | Laboratory-retained | 1 | MARGINAL |